Pediatric cardiac arrest remains a significant cause of mortality and morbidity and thus it is an important public health problem. Hypoxic ischemic encephalopathy is the limiting factor for intact neurological recovery in a majority of pediatric patients after cardiac arrest. Cerebral blood flow disturbances may further contribute to neuropathological damage after cardiac arrest and represent an important target for novel therapies. Our long term research goal is to elucidate key vascular pathways involved in pathologic cerebral blood flow dysregulation after pediatric asphyxial cardiac arrest and to develop therapeutic strategies that prevent cerebral blood flow dysregulation and secondary neuronal damage. Compelling preliminary data suggest that the balance of vasoconstrictive and vasodilator eicosanoid metabolites of cytochrome P450 is disturbed in favor of vasoconstrictors after experimental pediatric cardiac asphyxial arrest. Furthermore, inhibiting the production of vasoconstrictive eicosanoids prevented the cortical hypoperfusion and improved neurological outcome in our pediatric asphyxial cardiac arrest model. The goal of this project is to elucidate mechanisms through which eicosanoid metabolites of cytochrome P450 4A/4F and 2C/2J produce cerebral blood flow dysregulation and neurotoxicity after pediatric cardiac arrest and to develop innovative therapies that target these pathways. We propose to 1) define the role of vasoconstrictor eicosanoids in cerebral blood flow dysregulation and neurodegeneration after pediatric cardiac arrest, 2) define the role of vasodilatatory eicosanoids in cerebral blood flow normalization and neuroprotection after pediatric cardiac arrest and 3) determine if inhibiting eicosanoid-induced vasoconstriction and enhancing eicosanoid- induced vasodilatation improves neurological outcome after pediatric cardiac arrest. We propose innovative approaches to assessing the neurovascular unit from both vascular and neuronal perspectives, from the molecular to the global level. We have assembled a collaborative team of experts in (i) mass spectrometry with expertise using a comprehensive lipidomic approach, (ii) cerebral blood flow assessment by arterial spin label magnetic resonance imaging, (iii) cell imaging for in vivo visualization of cortical microcirculation via two photon microscopy, and (iv) an outcome animal model of cardiac arrest. If these dual vascular- and neuronal-targeted therapies reduce secondary neuronal damage and improve outcome after pediatric asphyxial cardiac arrest, then clinical translation of this novel approach would be of significant impact for infants and children who suffer cardiac arrest.
Pediatric cardiac arrest is a significant public health problem, with high mortality and morbidity. A majority of children surviving cardiac arrest are left with neurological impairment, underscoring the need for innovative therapeutic strategies aimed at improving the quality of life after pediatric cardiac arrest. This project will elucidate mechanism of cerebral blood flow disturbances and neurotoxicity after pediatric cardiac arrest, and will use dual vascular- and neuronal- therapies with the goal of reducing neuronal damage and improving neurological outcome after pediatric cardiac arrest.
|Wallisch, Jessica S; Janesko-Feldman, Keri; Alexander, Henry et al. (2018) The aquaporin-4 inhibitor AER-271 blocks acute cerebral edema and improves early outcome in a pediatric model of asphyxial cardiac arrest. Pediatr Res :|
|Li, Lingjue; Poloyac, Samuel M; Watkins, Simon C et al. (2017) Cerebral microcirculatory alterations and the no-reflow phenomenon in vivo after experimental pediatric cardiac arrest. J Cereb Blood Flow Metab :271678X17744717|
|Ansari, Mohammad Zaheer; Kang, Eun-Jeung; Manole, Mioara D et al. (2017) Monitoring microvascular perfusion variations with laser speckle contrast imaging using a view-based temporal template method. Microvasc Res 111:49-59|
|Iordanova, Bistra; Li, Lingjue; Clark, Robert S B et al. (2017) Alterations in Cerebral Blood Flow after Resuscitation from Cardiac Arrest. Front Pediatr 5:174|
|Foley, Lesley M; Clark, Robert S B; Vazquez, Alberto L et al. (2017) Enduring disturbances in regional cerebral blood flow and brain oxygenation at 24?h after asphyxial cardiac arrest in developing rats. Pediatr Res 81:94-98|
|Shaik, Jafar Sadik B; Poloyac, Samuel M; Kochanek, Patrick M et al. (2015) 20-Hydroxyeicosatetraenoic Acid Inhibition by HET0016 Offers Neuroprotection, Decreases Edema, and Increases Cortical Cerebral Blood Flow in a Pediatric Asphyxial Cardiac Arrest Model in Rats. J Cereb Blood Flow Metab 35:1757-63|
|Simon, Dennis W; Fink, Ericka L; Manole, Mioara D (2015) Pediatric Out-of-Hospital Cardiac Arrest Outcomes: A Case of Male/Female Inequality? Pediatr Crit Care Med 16:779-80|
|Drabek, Tomas; Foley, Lesley M; Janata, Andreas et al. (2014) Global and regional differences in cerebral blood flow after asphyxial versus ventricular fibrillation cardiac arrest in rats using ASL-MRI. Resuscitation 85:964-71|
|Shaik, Jafar Sadik B; Miller, Tricia M; Graham, Steven H et al. (2014) Rapid and simultaneous quantitation of prostanoids by UPLC-MS/MS in rat brain. J Chromatogr B Analyt Technol Biomed Life Sci 945-946:207-16|
|Tress, Erika E; Clark, Robert S B; Foley, Lesley M et al. (2014) Blood brain barrier is impermeable to solutes and permeable to water after experimental pediatric cardiac arrest. Neurosci Lett 578:17-21|
Showing the most recent 10 out of 11 publications